The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Automated Nucleic Acid Extraction Devices Market Be By 2030 Compared To Its 2026 Market Size?
The automated nucleic acid extraction devices market has experienced significant expansion in recent years. It is anticipated to increase from $6.6 billion in 2025 to $7.32 billion in 2026, registering a compound annual growth rate (CAGR) of 10.9%. The historical growth can be ascribed to several factors, including the expansion of molecular diagnostic testing, an increase in the prevalence of infectious diseases, the greater adoption of laboratory automation, growing clinical testing volumes, and advancements in nucleic acid chemistry.
The automated nucleic acid extraction devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $11.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. Factors driving this expansion during the projection period include a heightened need for swift diagnostic solutions, greater capital allocation towards genomic research, the broadening scope of personalized medicine testing, the increasing uptake of point-of-care molecular diagnostics, and advancements in extraction efficiency technologies. Key trends anticipated during the forecast encompass the wider adoption of fully automated extraction platforms, a surge in demand for high-throughput molecular diagnostics, the expanding deployment of integrated sample-to-result systems, the scaling up of automated laboratory workflows, and an intensified emphasis on processing free from contamination.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9421&type=smp
Which Primary Drivers Are Impacting The Automated Nucleic Acid Extraction Devices Market Growth?
The growing occurrence of infectious diseases is anticipated to propel the expansion of the automated nucleic acid extraction devices market in the future. An infectious disease is defined as an ailment resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, which can spread, either directly or indirectly, between individuals or from animals to humans. This rise in infectious diseases, especially during worldwide health emergencies such as pandemics, intensifies the demand for diagnostic tests. In this context, automated nucleic acid extraction devices are crucial for sample preparation in molecular diagnostics, aiding in the identification of viruses and bacteria. For example, data from GOV.UK, a UK-based public sector information site, indicates that in September 2023, tuberculosis (TB) cases in England showed a 7% increase in the first half of 2023 compared to the same period in 2022, with reported cases climbing from 2,251 to 2,408. Consequently, the rising incidence of infectious diseases is fueling the expansion of the automated nucleic acid extraction devices market.
How Is The Automated Nucleic Acid Extraction Devices Market Broken Down By Segment Categories?
The automated nucleic acid extraction devices market covered in this report is segmented –
1) By Type: Instruments, Kits, Consumables
2) By Automation Level: Fully Automated, Semi-Automated
3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes
Subsegments:
1) By Instruments: Automated Extractors, Liquid Handling Systems
2) By Kits: DNA Extraction Kits, RNA Extraction Kits, Viral Nucleic Acid Extraction Kits
3) By Consumables: Reagents, Columns, Tips And Tubes
Which Trends Are Shaping Growth In The Automated Nucleic Acid Extraction Devices Market?
Leading companies in the automated nucleic acid extraction devices market are developing advanced products, such as automated nucleic acid extraction workstations, to attract a larger customer base, increase sales, and boost revenue. An automated nucleic acid extraction workstation is a specialized and automated system designed for isolating nucleic acids, including DNA and RNA, from biological samples. For example, in April 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based company providing in-vitro diagnostic products, introduced the SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method). The SAW-48 is a unique in-vitro diagnostic medical device that integrates sample loading, nucleic acid purification, and PCR setup into a single instrument. This innovative device can process up to 48 samples simultaneously, significantly reducing the time needed to obtain test results. The SAW-48 optimizes the entire sequence of sample loading, nucleic acid purification, and PCR setup, improving the efficiency of STD and HPV detection. Both the SAW-48 and the Cell Nucleic Acid Extraction Kit together provide a complete solution, ensuring a more efficient and streamlined method for the detection of sexually transmitted diseases and human papillomavirus.
Which Players Are Present In The Automated Nucleic Acid Extraction Devices Market Space?
Major companies operating in the automated nucleic acid extraction devices market are QIAGEN N.V., PerkinElmer Inc., F. Hoffmann-La Roche AG, Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Tecan Group Ltd., Merck KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Xi’an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., MicroGEM International Company, Norgen Biotek Corp.
Get The Full Automated Nucleic Acid Extraction Devices Market Report:
Which Region Is The Top Contributor To The Automated Nucleic Acid Extraction Devices Market By Share?
North America was the largest region in the automated nucleic acid extraction devices market in 2025. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Automated Nucleic Acid Extraction Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=9421&type=smp
Browse Through More Reports Similar to the Global Automated Nucleic Acid Extraction Devices Market 2026, By The Business Research Company
Nucleic Acid Extraction Instruments And Reagents Market Report 2026
Nucleic Acid Labeling Market Report 2026
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Dna Or Rna Sample Extraction And Isolation Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model